D. Back

发表

Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells

A. Owen, Philip Martin, P. Martin, 2008, British journal of pharmacology.

Pharmacokinetic and Pharmacodynamic Analysis of Efavirenz Dose Reduction Using an In Vitro–In Vivo Extrapolation Model

C. Marzolini, C. Csajka, A. Owen, 2012, Clinical pharmacology and therapeutics.

Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population

M. Youle, S. Khoo, C. Smith, 2009, HIV medicine.

Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir

E. Jones, A. Owen, S. Ward, 2008, British journal of pharmacology.

The Relationships of ABCB1 3435C>T and CYP2B6 516G>T With High‐Density Lipoprotein Cholesterol in HIV‐Infected Patients Receiving Efavirenz

M. Youle, S. Khoo, C. Smith, 2009, Clinical pharmacology and therapeutics.

Factors affecting the enterohepatic circulation of oral contraceptive steroids

M. Orme, D. Back, 1990, American journal of obstetrics and gynecology.

Pharmacogenetics of pregnancy‐induced changes in efavirenz pharmacokinetics

S. Khoo, A. Owen, L. Else, 2015, Clinical pharmacology and therapeutics.

A Longitudinal Study of Maternal Dose Response to Low Molecular Weight Heparin in Pregnancy

D. Back, S. Quenby, C. Toh, 2003, Obstetrics and gynecology.

Correlation between Intracellular Pharmacological Activation of Nucleoside Analogues and HIV Suppression in Vitro

D. Back, D. Sunderland, S. Khoo, 2000, Antiviral chemistry & chemotherapy.

Pharmacokinetics and Safety of Saquinavir/Ritonavir and Omeprazole in HIV‐infected Subjects

B. Gazzard, C. Fletcher, M. Boffito, 2008, Clinical pharmacology and therapeutics.

Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study

D. Cooper, P. Phanuphak, S. Khoo, 2015, Clinical pharmacology and therapeutics.

The impact of pharmacogenetics on HIV therapy

A. Owen, T. Mahungu, D. Back, 2009, International journal of STD & AIDS.

A Compartmental Pharmacokinetic Evaluation of Long‐Acting Rilpivirine in HIV‐Negative Volunteers for Pre‐Exposure Prophylaxis

B. Gazzard, B. Herold, M. Boffito, 2014, Clinical pharmacology and therapeutics.

The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine

A. Owen, C. Merry, P. Byakika-Kibwika, 2017, Clinical pharmacology and therapeutics.

Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy

Jackson, V. Jackson, J. Lambert, 2014, HIV medicine.

Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy

V. Jackson, L. Dickinson, D. Back, 2011, HIV medicine.

Intramuscular loading dose of quinine for falciparum malaria: pharmacokinetics and toxicity.

K. Silamut, D. Warrell, S. Looareesuwan, 1986, British medical journal.

Pharmacokinetics of mefloquine in the presence of primaquine

J. Karbwang, D. Bunnag, D. Back, 2004, European Journal of Clinical Pharmacology.

A comparison of the pharmacokinetics of mefloquine in healthy Thai volunteers and in Thai patients with falciparum malaria

A. Breckenridge, J. Karbwang, D. Bunnag, 2004, European Journal of Clinical Pharmacology.

The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects

A. Breckenridge, J. Karbwang, D. Bunnag, 2004, European Journal of Clinical Pharmacology.

Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.

M. Molyneux, D. Warrell, S. Looareesuwan, 1987, British journal of clinical pharmacology.

Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat

F. Sutcliffe, D. Back, J. Tjia, 1984, British journal of pharmacology.

Therapeutic drug monitoring (TDM) of atazanavir in pregnancy

V. Jackson, D. Back, M. Brennan, 2008, Journal of the International AIDS Society.

Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug

A. Silman, I. Bruce, S. Hider, 2006, Annals of the rheumatic diseases.

The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC

A. Owen, J. Sathish, D. Back, 2009, British journal of pharmacology.

Current uses and future hopes for clinical pharmacology in the management of HIV infection

S. Khoo, D. Back, S. Gibbons, 2000, HIV medicine.

Pharmacokinetics of mefloquine in combination with sulfadoxine-pyrimethamine and primaquine in male Thai patients with falciparum malaria.

A. Breckenridge, J. Karbwang, D. Bunnag, 1990, Bulletin of the World Health Organization.

Pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers.

A. Winston, L. Dickinson, J. Ashby, 2011, The Journal of antimicrobial chemotherapy.